Could lawmakers crack CVS’s grip on the prescription drug supply chain?

CVS owns health insurer Aetna and pharmacy benefit manager Caremark, allowing it to control how medications are priced, prescribed, and dispensed.

Bernstein Litowitz Berger & Grossmann Announces Filing of Racketeering Class Action Against CaremarkPCS and CVS Health Corporation

Bernstein Litowitz Berger & Grossmann LLP (BLB&G) announces the filing of a class action against leading pharmacy benefits manager CaremarkPCS Health, LLC along with its corporate ...
Fierce Healthcare

FTC seeing 'progress' in discussions with Optum, Caremark in insulin case

The Federal Trade Commission (FTC) may be nearing settlements with the remaining two pharmacy benefit managers involved in a lawsuit over insulin pricing. | The Federal Trade Commission may be nearing ...
Healthcare Dive

Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC

It’s looking increasingly likely that the UnitedHealth and CVS drug middlemen will also make peace with federal regulators, ...
Benzinga.com

CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder

CVS Health Inc. (NYSE: CVS) on Thursday said it is taking additional steps to lower prescription drug costs by expanding access to biosimilar medications, announcing new formulary changes that will ...

Why are your drug prices high? Reforms slow to make it to New Jersey

Reforming the prescription system could lead to major savings for patients, with one report putting the number as high as $100 billion annually.
Cancer Therapy Advisor

What Are PBMs, and How Do They Impact Drug Costs and Cancer Care?

Pharmacy benefit managers (PBMs) have used market leverage to demand rebates, which can lead drug manufacturers to increase sticker prices.